Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunoglobulin Prophylaxis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT06958796
What this trial is testing

Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)

Who this might be right for
CytomegalovirusOrgan TransplantKidney Transplant; Complications+2 more
Camille N. Kotton, MD 80
Large-scale testing (Phase 3)Study completedNCT00000751
What this trial is testing

A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)

Who this might be right for
HIV InfectionsPregnancy
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 1,600
Post-approval studies (Phase 4)WithdrawnNCT03192371
What this trial is testing

Evaluate the One Year Long-term Persistence of Immune Responses Following Two Different Rabies Vaccine Post-exposure Regimens in Chinese Children

Who this might be right for
Virus Diseases
GlaxoSmithKline
Testing effectiveness (Phase 2)Study completedNCT00442169
What this trial is testing

Safety and Immunogenicity of ChimeriVax-WN02 West Nile Vaccine in Healthy Adults

Who this might be right for
West Nile Fever
Sanofi Pasteur, a Sanofi Company 208
Post-approval studies (Phase 4)Study completedNCT01430403
What this trial is testing

Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations

Who this might be right for
Asthma
National Institute of Allergy and Infectious Diseases (NIAID) 478
Early research (Phase 1)UnknownNCT01937455
What this trial is testing

A Phase 1, Randomized, Blinded, Dose-escalation Study of rAAV1-PG9DP Recombinant AAV Vector Coding for PG9 Antibody in Healthy Male Adults.

Who this might be right for
HIV Infections
International AIDS Vaccine Initiative 21
Large-scale testing (Phase 3)Study completedNCT02954926
What this trial is testing

Intravenous Immunoglobulin in Prevention of Preterm Neonatal Sepsis

Who this might be right for
Neonatal Sepsis
Hormozgan University of Medical Sciences 92
Testing effectiveness (Phase 2)Study completedNCT04046549
What this trial is testing

Evaluate the Safety and Efficacy of Dual Costimulation Blockade With VIB4920 and Belatacept for Prophylaxis of Allograft Rejection in Adults Receiving a Kidney Transplant

Who this might be right for
AllograftsRejection; Transplant, KidneyTransplant Rejection+1 more
Amgen 25
Early research (Phase 1)Ended earlyNCT03565315
What this trial is testing

Phase I Study to Evaluate a Human Monoclonal Antibody (MAb) 10E8VLS Administered Alone or Concurrently With MAb VRC07-523LS Via Subcutaneous Injection in Healthy Adults

Who this might be right for
Healthy Adult Immune Response
National Institute of Allergy and Infectious Diseases (NIAID) 9
Testing effectiveness (Phase 2)UnknownNCT06453135
What this trial is testing

Eculizumab for Prevention of Antibody-Mediated Rejection in ABO-Incompatible Living Donor Kidney Transplantation

Who this might be right for
Kidney Transplantation
Tao Lin 30
Large-scale testing (Phase 3)Study completedNCT00881517
What this trial is testing

Efficacy Study of Human Cytomegalovirus (HCMV) Hyperimmune Globulin to Prevent Congenital HCMV Infection

Who this might be right for
Cytomegalovirus Infection
Fondazione IRCCS Policlinico San Matteo di Pavia 124
Not applicableUnknownNCT03146338
What this trial is testing

Prophylaxis of Magnesium-rich Mineral Water to Prevent Hypomagnesemia Induced by an Anti-EGFR (OPTIMAG)

Who this might be right for
Metastatic Colorectal CancerMetastatic Head and Neck Cancer
Weprom 106
Not applicableStudy completedNCT00761020
What this trial is testing

Merozoite Surface Protein 1 Antibody Response in Asymptomatic Human Malaria Infection

Who this might be right for
Malaria
U.S. Army Medical Research and Development Command 31
Early research (Phase 1)Study completedNCT01993706
What this trial is testing

Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), Administered Intravenously or Subcutaneously to Healthy Adults

Who this might be right for
HIV InfectionMonoclonal Antibody, HumanHIV Antibodies+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 29
Testing effectiveness (Phase 2)Study completedNCT05027074
What this trial is testing

Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007)

Who this might be right for
End-Stage Renal DiseaseEnd-Stage Kidney DiseaseKidney Failure, Chronic
Merck Sharp & Dohme LLC 506
Testing effectiveness (Phase 2)Looking for participantsNCT05972135
What this trial is testing

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

Who this might be right for
Multiple Myeloma
SCRI Development Innovations, LLC 100
Post-approval studies (Phase 4)UnknownNCT00196417
What this trial is testing

The HIT-TRAP Trial

Who this might be right for
Heparin-Induced Thrombocytopenia
University Medicine Greifswald 600
Testing effectiveness (Phase 2)Study completedNCT00601731
What this trial is testing

Evaluation of Meningococcal ACWY Immune Response in Children Aged 40 and 60 Months

Who this might be right for
Meningococcal Disease
Novartis Vaccines 382
Post-approval studies (Phase 4)Study completedNCT00310687
What this trial is testing

Persistence of Immune Response After Vaccination With MCC

Who this might be right for
Prevention of Meningococcal Infection
Novartis 1,244
Large-scale testing (Phase 3)Study completedNCT06039449
What this trial is testing

Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2

Who this might be right for
COVID-19SARS-CoV-2
Invivyd, Inc. 790
Next Page